Sunday, 02 August 2026 · World
USD/EUR 0.8685 USD/GBP 0.743 USD/JPY 158.3 USD/CNY 6.769 All rates →
RSS
EUROS The World Financial Report
Nº 22 Sunday, 02 August 2026 · World Edition
LATEST
Markets

Novo Nordisk shares in hot water after disappointing trial

TST (Full) - (Official Feed) · 1h ago
Novo Nordisk shares in hot water after disappointing trial

Investors who had hopes that Novo Nordisk (NVO) could succeed outside of weight-loss drugs were disappointed on Friday, July 31. The Danish drugmaker said its experimental heart drug Ziltivekimab failed the main goal of a large late-stage trial, and the stock fell fast. Novo has spent 2026 trying ...

Read the full story at TST (Full) - (Official Feed) →